









Mercado
/
Acciones
/
nasdaq-rmd
/

Resmed Inc

RMD

240.880USD

-2.200-0.91%

Cierre 12/31, 16:00（ET）Cotizaciones retrasadas 15 min

35.15BCap. mercado

24.55P/E TTM



Resmed Inc

240.880

-2.200-0.91%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Resmed Inc Compañía

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

Información de Resmed Inc



Símbolo de cotizaciónRMD

Nombre de la empresaResmed Inc

Fecha de salida a bolsaJun 01, 1995

Director ejecutivoFarrell (Michael J)

Número de empleados10600

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 01

Dirección9001 Spectrum Center Blvd

CiudadSAN DIEGO

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal92123

Teléfono18587462400

Sitio Webhttps://www.resmed.com/

Símbolo de cotizaciónRMD

Fecha de salida a bolsaJun 01, 1995

Director ejecutivoFarrell (Michael J)

Ejecutivos de Resmed Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael J. (Mick) Farrell

Chairman of the Board, Chief Executive Officer

449.52K

Mr. Brett A. Sandercock

Chief Financial Officer

79.62K

-1.24%

Mr. Ronald R. (Ron) Taylor

Lead Independent Director

24.77K

+4.53%

Ms. Carol J. Burt

Independent Director

18.82K

+6.05%

Ms. Harjit Gill

Independent Director

10.94K

+10.45%

Ms. Karen Drexler

Independent Director

10.60K

+11.26%

Dr. Desney Tan

Independent Director

6.00K

+21.77%

Ms. Nicole Mowad-Nassar

Independent Director

Mr. John B. Hernandez

Independent Director

Mr. Justin M. W. Leong

Chief Product Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael J. (Mick) Farrell

Chairman of the Board, Chief Executive Officer

449.52K

Mr. Brett A. Sandercock

Chief Financial Officer

79.62K

-1.24%

Mr. Ronald R. (Ron) Taylor

Lead Independent Director

24.77K

+4.53%

Ms. Carol J. Burt

Independent Director

18.82K

+6.05%

Ms. Harjit Gill

Independent Director

10.94K

+10.45%

Ms. Karen Drexler

Independent Director

10.60K

+11.26%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Devices

2.67B

51.79%

Masks and other

1.84B

35.75%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

3.29B

63.84%

Rest of the world

1.86B

36.16%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Devices

2.67B

51.79%

Masks and other

1.84B

35.75%

Estadísticas de accionistas

Actualizado: dom., 16 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

13.00%

BlackRock Institutional Trust Company, N.A.

5.92%

State Street Investment Management (US)

4.49%

Geode Capital Management, L.L.C.

2.91%

Walter Scott & Partners Ltd.

1.93%

Otro

71.75%

Accionistas

Proporción

The Vanguard Group, Inc.

13.00%

BlackRock Institutional Trust Company, N.A.

5.92%

State Street Investment Management (US)

4.49%

Geode Capital Management, L.L.C.

2.91%

Walter Scott & Partners Ltd.

1.93%

Otro

71.75%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

38.51%

Investment Advisor/Hedge Fund

19.37%

Pension Fund

2.46%

Research Firm

2.24%

Bank and Trust

1.36%

Sovereign Wealth Fund

0.88%

Hedge Fund

0.77%

Individual Investor

0.51%

Corporation

0.11%

Otro

33.78%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1779

95.72M

65.58%

-1.54M

2025Q3

1773

95.81M

65.64%

-3.83M

2025Q2

1772

96.52M

65.83%

-8.52M

2025Q1

1781

97.60M

66.56%

-6.39M

2024Q4

1734

93.56M

63.70%

-7.66M

2024Q3

1652

90.85M

61.90%

-10.07M

2024Q2

1605

89.55M

60.95%

-7.66M

2024Q1

1565

87.15M

59.25%

-8.40M

2023Q4

1535

84.78M

57.62%

-16.98M

2023Q3

1539

92.21M

62.70%

-12.21M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

18.97M

13%

+292.08K

+1.56%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

8.65M

5.92%

-28.73K

-0.33%

Sep 30, 2025

State Street Investment Management (US)

6.55M

4.49%

-66.69K

-1.01%

Sep 30, 2025

Geode Capital Management, L.L.C.

4.25M

2.91%

+36.54K

+0.87%

Sep 30, 2025

Walter Scott & Partners Ltd.

2.82M

1.93%

-470.65K

-14.32%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

1.19M

0.81%

+669.17K

+129.03%

Jun 30, 2025

Northern Trust Investments, Inc.

1.16M

0.79%

-9.99K

-0.86%

Sep 30, 2025

Invesco Capital Management LLC

1.12M

0.77%

-44.31K

-3.80%

Sep 30, 2025

BlackRock Asset Management Ireland Limited

1.11M

0.76%

-19.66K

-1.74%

Sep 30, 2025

Charles Schwab Investment Management, Inc.

1.07M

0.73%

+46.64K

+4.57%

Sep 30, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

Langar Global HealthTech ETF

9.06%

First Trust Nasdaq Lux Digi Health Solutions ETF

7.21%

Pacer US Cash Cows Growth ETF

4.31%

iShares U.S. Medical Devices ETF

4.09%

Global X HealthTech ETF

4.02%

ERShares Entrepreneurs ETF

2.49%

Siren DIVCON Dividend Defender ETF

2.22%

SEI Enhanced US Large Cap Quality Factor ETF

1.92%

First Trust Growth Strength ETF

1.83%

First Trust Indxx Medical Devices ETF

1.82%

Langar Global HealthTech ETF

Proporción9.06%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción7.21%

Pacer US Cash Cows Growth ETF

Proporción4.31%

iShares U.S. Medical Devices ETF

Proporción4.09%

Global X HealthTech ETF

Proporción4.02%

ERShares Entrepreneurs ETF

Proporción2.49%

Siren DIVCON Dividend Defender ETF

Proporción2.22%

SEI Enhanced US Large Cap Quality Factor ETF

Proporción1.92%

First Trust Growth Strength ETF

Proporción1.83%

First Trust Indxx Medical Devices ETF

Proporción1.82%

Dividendos



Un total de 1.32B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Jan 30, 2025

RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 20, 2025 going ex on Feb 13, 2025

Feb 13, 2025

Mar 20, 2025

Feb 13, 2025

Oct 25, 2024

RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Dec 12, 2024 going ex on Nov 07, 2024

Nov 07, 2024

Dec 12, 2024

Nov 07, 2024

Aug 01, 2024

RMD.NB Final Cash Dividend of gross USD 0.53 paid on Sep 19, 2024 going ex on Aug 15, 2024

Aug 15, 2024

Sep 19, 2024

Aug 15, 2024

Apr 25, 2024

RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Jun 13, 2024 going ex on May 08, 2024

May 09, 2024

Jun 13, 2024

May 08, 2024

Jan 25, 2024

RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Mar 14, 2024 going ex on Feb 07, 2024

Feb 08, 2024

Mar 14, 2024

Feb 07, 2024

Oct 27, 2023

RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Dec 14, 2023 going ex on Nov 08, 2023

Nov 09, 2023

Dec 14, 2023

Nov 08, 2023

Aug 03, 2023

RMD.NB Final Cash Dividend of gross USD 0.48 paid on Sep 21, 2023 going ex on Aug 16, 2023

Aug 17, 2023

Sep 21, 2023

Aug 16, 2023

Apr 28, 2023

RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Jun 15, 2023 going ex on May 10, 2023

May 11, 2023

Jun 15, 2023

May 10, 2023

Jan 27, 2023

RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Mar 16, 2023 going ex on Feb 08, 2023

Feb 09, 2023

Mar 16, 2023

Feb 08, 2023

Oct 27, 2022

RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Dec 15, 2022 going ex on Nov 09, 2022

Nov 10, 2022

Dec 15, 2022

Nov 09, 2022

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Resmed Inc?



Los cinco principales accionistas de Resmed Inc son:
The Vanguard Group, Inc. posee 18.97M acciones, lo que representa el 13.00% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 8.65M acciones, lo que representa el 5.92% del total de acciones.
State Street Investment Management (US) posee 6.55M acciones, lo que representa el 4.49% del total de acciones.
Geode Capital Management, L.L.C. posee 4.25M acciones, lo que representa el 2.91% del total de acciones.
Walter Scott & Partners Ltd. posee 2.82M acciones, lo que representa el 1.93% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Resmed Inc?



Los tres principales tipos de accionista de Resmed Inc son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

¿Cuántas instituciones poseen acciones de Resmed Inc (RMD)?



A fecha de 2025Q4, 1779 instituciones poseen acciones de Resmed Inc, con un valor de mercado combinado de aproximadamente 95.72M, lo que representa el 65.58% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.06%.

¿Cuál es la mayor fuente de ganancias de Resmed Inc?



El FY2025, el segmento empresarial Devices generó la ganancia más alta para Resmed Inc, ascendiendo a 2.67B y representando el 51.79% de la ganancia total.

KeyAI

